GW0742

GW0742
Systematic (IUPAC) name
	[4-[[[2-[3-fluoro-4-(trifluoromethyl)phenyl]-4-methyl-5-thiazolyl]methyl]thio]-2-methyl phenoxy]-acetic acid
Clinical data
Pregnancy; category	N/A;
Legal status	Investigational;
Identifiers
CAS Number	317318-84-6
ATC code	None
PubChem	CID: 9934458
IUPHAR/BPS	2686
ChemSpider	8110086
ChEBI	CHEBI:156132
ChEMBL	CHEMBL38508
Chemical data
Formula	C21H17F4NO3S2
Molecular mass	471.488 g/mol
	SMILES FC(F)(F)c3c(F)cc(c1nc(c(s1)CSc2cc(c(OCC(=O)O)cc2)C)C)cc3 ;
	InChI InChI=InChI=1S/C21H17F4NO3S2/c1-11-7-14(4-6-17(11)29-9-19(27)28)30-10-18-12(2)26-20(31-18)13-3-5-15(16(22)8-13)21(23,24)25/h3-8H,9-10H2,1-2H3,(H,27,28) ; Key:HWVNEWGKWRGSRK-UHFFFAOYSA-N ;

GW0742 (also known as GW610742) is a PPARδ/β agonist^[2]^[3]^[4] that is investigated for drug use by GlaxoSmithKline.^{[citation needed]}

References

This pharmacology-related article is a stub. You can help Wikipedia by expanding it.

Systematic (IUPAC) name

[4-[[[2-[3-fluoro-4-(trifluoromethyl)phenyl]-4-methyl-5-thiazolyl]methyl]thio]-2-methyl phenoxy]-acetic acid^[1]
Clinical data
Pregnancy category	N/A
Legal status	Investigational
Identifiers
CAS Number	317318-84-6
ATC code	None
PubChem	CID: 9934458
IUPHAR/BPS	2686
ChemSpider	8110086
ChEBI	CHEBI:156132
ChEMBL	CHEMBL38508
Chemical data
Formula	C₂₁H₁₇F₄NO₃S₂
Molecular mass	471.488 g/mol
SMILES FC(F)(F)c3c(F)cc(c1nc(c(s1)CSc2cc(c(OCC(=O)O)cc2)C)C)cc3
InChI InChI=InChI=1S/C21H17F4NO3S2/c1-11-7-14(4-6-17(11)29-9-19(27)28)30-10-18-12(2)26-20(31-18)13-3-5-15(16(22)8-13)21(23,24)25/h3-8H,9-10H2,1-2H3,(H,27,28) Key:HWVNEWGKWRGSRK-UHFFFAOYSA-N